Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 03 symbols : Nvs save search
Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team
Published: 2021-08-03 (Crawled : 13:00) - biospace.com/
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
PIRS | $0.163 3.76% 180K
|
Health Technology
|
| O: 1.42%
H: 2.38%
C: 1.96%
Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
TAK | $13.185 0.27% 570K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: -0.6%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
XNCR | $19.0 -0.37% 120K
|
Health Technology
|
| O: 0.55%
H: 1.32%
C: 1.03%
MOR | News | $18.0 -0.22% 66K
|
Health Technology
|
| O: -2.43%
H: 0.88%
C: 0.44%
INCY | $52.46 -0.49% 330K
|
Health Technology
|
| O: -0.7%
H: 0.31%
C: 0.04%
financial results results
Novartis announces lift of partial clinical trial hold and plans to initiate a new, pivotal Phase 3 study of intrathecal OAV-101 in older patients with SMA
Published: 2021-08-03 (Crawled : 06:00) - globenewswire.com
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
phase 3 trial order
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
INVO | $1.36 78.95% 3.6M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
ALRN | $5.53 30.12% 250K
|
Health Technology
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.